03.01.13
The Cannabis Committee of the American Herbal Products Association (AHPA), Silver Spring, MD, has delivered draft recommendations on the regulation of distribution (dispensing) of medical marijuana to regulators in three states that allow such practice. The recommendations seek to ensure best practices at the point of distribution between provider and consumer and cover such issues as product acquisition, physical facilities, security, personnel training and requirements for purchase.
The committee’s recommendations were delivered to regulatory offices in California, Colorado and Massachusetts and will be sent to other states that legalized medical marijuana and to the District of Columbia.
The AHPA Cannabis Committee was founded in 2010 to address issues related to the safe use and responsible commerce of legally marketed products derived from Cannabis species. The committee, in cooperation with Americans for Safe Access (ASA), has over the past year coordinated the development of recommendations to state regulators on best practice regulations in several areas, including cultivation; manufacturing, packaging and labeling; laboratory practice; and distribution.
The committee’s recommendations were delivered to regulatory offices in California, Colorado and Massachusetts and will be sent to other states that legalized medical marijuana and to the District of Columbia.
The AHPA Cannabis Committee was founded in 2010 to address issues related to the safe use and responsible commerce of legally marketed products derived from Cannabis species. The committee, in cooperation with Americans for Safe Access (ASA), has over the past year coordinated the development of recommendations to state regulators on best practice regulations in several areas, including cultivation; manufacturing, packaging and labeling; laboratory practice; and distribution.